Regenerative therapy with mesenchymal stem cells at the site of malignant primary bone tumour resection: what are the risks of early or late local recurrence?
Crossref DOI link: https://doi.org/10.1007/s00264-014-2384-0
Published Online: 2014-06-07
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hernigou, Philippe
Flouzat Lachaniette, Charles Henri
Delambre, Jerome
Chevallier, Nathalie
Rouard, Helene
Text and Data Mining valid from 2014-06-07